I Dacheva1, M Reich1,2, M Nobl1, K Ceglowska1,3, J Wasiak1, J Siwy4, P Zürbig4, H Mischak4,5, F H J Koch6, J Kopitz7, F T A Kretz1, T Tandogan1, G U Auffarth1, M J Koss8,9. 1. Universitätsaugenklinik Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. 2. Augenklinik, Albert-Ludwigs-University Freiburg, Freiburg, Deutschland. 3. Medical Research Centre, Polish Academy of Science, Warsaw, Polen. 4. Mosaiques Diagnostics GmbH, Hannover, Deutschland. 5. BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. 6. Augenklinik, Goethe-Universität, Frankfurt am Main, Deutschland. 7. Pathologisches Institut, Universität Heidelberg, Heidelberg, Deutschland. 8. Universitätsaugenklinik Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. michael.koss@me.com. 9. Department of Ophthalmology, University of Southern California, Los Angeles, CA, USA. michael.koss@me.com.
Abstract
BACKGROUND: The pathophysiological mechanisms of macular edema secondary to branch retinal vein occlusion (BRVO) remain unclear. OBJECTIVES: To analyze the protein profile of human vitreous of patients with BRVO and to identify specific dysregulated proteins. MATERIALS AND METHODS: Undiluted vitreous humor samples from patients with treatment naïve BRVO and 15 controls with idiopathic floaters were analyzed in this clinical-experimental study using capillary electrophoresis coupled to a mass spectrometer (CE-MS) and tandem mass spectrometry (MS/MS). Quantitative analysis of the dysregulated proteins was performed with enzyme-linked immunosorbent assay (ELISA). Protein-protein interactions were depicted with the STRING database. RESULTS: A total of 84 proteins were found in the human vitreous samples of 15 patients with BRVO and 15 controls. In all, 14 proteins were significant when comparing the signal intensities of BRVO and control samples. Six significant dysregulated proteins with p < 0.001 were further verified with ELISA. Clusterin, complement factor C3, prostaglandin-H2 D‑isomerase and vitronectin were significantly upregulated in the BRVO group and opticin was downregulated. The protein interactions analysis showed associations with inflammatory cascades, matrix changes, mechanisms of cell survival und death. CONCLUSIONS: The results of the study reveal that the proteomic composition of vitreous humor differed significantly between the patients with BRVO and the controls. Whether the identified proteins may serve as potential biomarkers for pathophysiology, diagnostics or therapy should be examine in further studies.
BACKGROUND: The pathophysiological mechanisms of macular edema secondary to branch retinal vein occlusion (BRVO) remain unclear. OBJECTIVES: To analyze the protein profile of human vitreous of patients with BRVO and to identify specific dysregulated proteins. MATERIALS AND METHODS: Undiluted vitreous humor samples from patients with treatment naïve BRVO and 15 controls with idiopathic floaters were analyzed in this clinical-experimental study using capillary electrophoresis coupled to a mass spectrometer (CE-MS) and tandem mass spectrometry (MS/MS). Quantitative analysis of the dysregulated proteins was performed with enzyme-linked immunosorbent assay (ELISA). Protein-protein interactions were depicted with the STRING database. RESULTS: A total of 84 proteins were found in the human vitreous samples of 15 patients with BRVO and 15 controls. In all, 14 proteins were significant when comparing the signal intensities of BRVO and control samples. Six significant dysregulated proteins with p < 0.001 were further verified with ELISA. Clusterin, complement factor C3, prostaglandin-H2 D‑isomerase and vitronectin were significantly upregulated in the BRVO group and opticin was downregulated. The protein interactions analysis showed associations with inflammatory cascades, matrix changes, mechanisms of cell survival und death. CONCLUSIONS: The results of the study reveal that the proteomic composition of vitreous humor differed significantly between the patients with BRVO and the controls. Whether the identified proteins may serve as potential biomarkers for pathophysiology, diagnostics or therapy should be examine in further studies.
Authors: John W Crabb; Masaru Miyagi; Xiaorong Gu; Karen Shadrach; Karen A West; Hirokazu Sakaguchi; Motohiro Kamei; Azeem Hasan; Lin Yan; Mary E Rayborn; Robert G Salomon; Joe G Hollyfield Journal: Proc Natl Acad Sci U S A Date: 2002-10-21 Impact factor: 11.205
Authors: Pingbo Zhang; Craig Dufresne; Randi Turner; Sara Ferri; Vidya Venkatraman; Rabia Karani; Gerard A Lutty; Jennifer E Van Eyk; Richard D Semba Journal: Proteomics Date: 2015-01-14 Impact factor: 3.984
Authors: Sebastian Aretz; Tim U Krohne; Kerstin Kammerer; Uwe Warnken; Agnes Hotz-Wagenblatt; Marion Bergmann; Boris V Stanzel; Tore Kempf; Frank G Holz; Martina Schnölzer; Jürgen Kopitz Journal: Proteome Sci Date: 2013-05-20 Impact factor: 2.480
Authors: Gabriel Velez; Peter H Tang; Thiago Cabral; Galaxy Y Cho; Daniel A Machlab; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan Journal: Transl Vis Sci Technol Date: 2018-09-26 Impact factor: 3.283
Authors: Sarah R Weber; Yuanjun Zhao; Christopher Gates; Jingqun Ma; Felipe da Veiga Leprevost; Venkatesha Basrur; Alexey I Nesvizhskii; Thomas W Gardner; Jeffrey M Sundstrom Journal: J Clin Med Date: 2021-05-25 Impact factor: 4.241